04.08.2016
RHÖN-KLINIKUM AG DE0007042301
DGAP-News: RHÖN-KLINIKUM AG: Interim Report for the First Six Months of 2016:RHÖN-KLINIKUM AG Continues its Strong Growth - Strategic Focus on Network Medicine and Digitalisation
DGAP-News: RHÖN-KLINIKUM AG / Key word(s): Half Year Results
RHÖN-KLINIKUM AG: Interim Report for the First Six Months of
2016:RHÖN-KLINIKUM AG Continues its Strong Growth - Strategic Focus on
Network Medicine and Digitalisation
04.08.2016 / 06:59
The issuer is solely responsible for the content of this announcement.
---------------------------------------------------------------------------
Press Release
Interim Report for the First Six Months of 2016: RHÖN-KLINIKUM AG Continues
its Strong Growth - Strategic Focus on Network Medicine and Digitalisation
- 414,403 patients treated
- Revenues stand at Euro 590.6 million
- EBITDA in the amount of Euro 103.4 million includes dissolving
provisions of Euro 41 million
- Outlook for 2016 remains unchanged: Revenues between Euro 1.17 billion
and Euro 1.20 billion, EBITDA between Euro 155 million and Euro 165
million
Bad Neustadt / Saale, 4th August 2016
RHÖN-KLINIKUM AG continued its strong growth during the first six months of
the current financial year 2016. In the first half-year a total of 414,403
patients were treated in the corporate hospitals at the five different
sites. Revenues for the period from January up to and including June stood
at Euro 590.6 million. Earnings before interest, taxes, depreciation and
amortisation (EBITDA) amounted to Euro 103.4 million including provisions
of roughly Euro 41 million which had mainly been set aside for warranty
claims from the sales transaction with Fresenius/Helios and were dissolved
in the first six months of the financial year. The current financial
figures are therefore not directly comparable with those of previous years
due to these ongoing effects on the balance sheet.
Outlook
For financial year 2016 we expect revenues of Euro 1.17 billion to Euro
1.20 billion and earnings before interest, taxes, depreciation and
amortisation (EBITDA) of between Euro 155 million and Euro 165 million.
Positive and negative one-off effects, the size of which will be a low to
medium two-digit million figure, will continue to influence the corporate
results during this financial year as well and will partially cancel each
other out. They mainly result from handling the transaction with Fresenius/
Helios, the initial consolidation and integration of the municipal hospital
in Bad Neustadt, special budgets for innovation and e-health, unresolved
accounting issues and setting up a substantial diagnostic and out-patient
clinic at the university hospital in Marburg.
Further legislative restrictions which will temporarily have a negative
impact on the organic growth of the Company are currently to be expected in
the largely regulated market environment in Germany. The Company must
expect a drop in revenues of roughly 1 % for the current financial year
arising, in particular, from the discounts on additional volume which were
agreed in 2013; corresponding counteractive measures have already been
introduced to neutralise the effects.
"It remains to be seen how the new law to reform the structures of hospital
care (Krankenhausstrukturgesetz - KHSG) will affect our business in the
medium to long term. Individual aspects of state-of-the-art healthcare will
in particular probably be subjected to a new basis for calculation weighted
in accordance with the heavier burdens," CEO Dr. Martin Siebert stated. "We
are prepared for this new challenge. We shall also be strong enough in the
future to persevere successfully and profitably in a continuously demanding
market environment."
"With targeted investments the Company will further develop and strengthen
its primary position to provide maximum cutting-edge medical care with a
direct link to universities, focussing particularly on digitalisation and
network medicine, the principal issues of the future. Together with the
Company's campus concept all these initiatives form the basis of
guaranteeing forward-looking healthcare which is constantly geared to
patient needs," Siebert added.
**************************************************************************
*************
RHÖN‐KLINIKUM AG is one of the largest healthcare providers in Germany. At
five medical sites with a total of 5,400 beds we offer cutting-edge medical
care with a direct link to universities and research institutes. Our top
five key areas of treatment are cardiological and coronary disease,
neurological disorders, oncology, lung diseases as well as orthopedic and
accident surgery. A total of over 16,000 employees work for RHÖN-KLINIKUM
AG. Our facilities are located in Bad Berka, Bad Neustadt/Saale, Frankfurt
(Oder) and Giessen and Marburg.
Further information is available at: www.rhoen-klinikum-ag.com.
Your Contact Persons:
RHÖN-KLINIKUM AG
Achim Struchholz
Group Division Head of Corporate Communication
Schlossplatz 1
97616 Bad Neustadt / Saale
Telephone: + 49 - 9771 65-1327
Facsimile: + 49 - 9771 65-1820
E-mail: [email protected]
Dr. Kai G. Klinger
Goup Division Head of Investor Relations & Group Financing
Schlossplatz 1
97616 Bad Neustadt / Saale
Telephone: + 49 - 9771 65-1318
Facsimile: + 49 - 9771 99-1736
E-mail: [email protected]
---------------------------------------------------------------------------
04.08.2016 Dissemination of a Corporate News, transmitted by DGAP - a
service of EQS Group AG.
The issuer is solely responsible for the content of this announcement.
The DGAP Distribution Services include Regulatory Announcements,
Financial/Corporate News and Press Releases.
Archive at www.dgap.de
---------------------------------------------------------------------------
Language: English
Company: RHÖN-KLINIKUM AG
Salzburger Leite 1
97616 Bad Neustadt a.d.Saale
Germany
Phone: +49 (0)9771 - 65-0
Fax: +49 (0)9771 - 97 467
E-mail: [email protected]
Internet: www.rhoen-klinikum-ag.com
ISIN: DE0007042301
WKN: 704230
Indices: MDAX
Listed: Regulated Market in Frankfurt (Prime Standard), Munich;
Regulated Unofficial Market in Berlin, Dusseldorf,
Hamburg, Stuttgart, Tradegate Exchange
End of News DGAP News Service
---------------------------------------------------------------------------
489315 04.08.2016
|
Weitere Ad-hoc und Unternehmensrelevante Mitteilungen zu
RHÖN-KLINIKUM AG ISIN: DE0007042301 können Sie bei EQS abrufen
Pflegeeinrichtungen , 704230 , RHK , XETR:RHK